Parkwood LLC’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Parkwood LLC’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,683	Closed	-$339K	–	212
2024 Q1	$339K	Buy	+9,683	New	+$353K	0.03%	167

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Parkwood LLC's INBX Position: Q2 2024 in Review

Parkwood LLC sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 9,683 shares — an estimated $339K sold.

Parkwood LLC first reported a position in INBX in Q1 2024 and held it in 1 quarter. The position peaked at $339K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Parkwood LLC reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Parkwood LLC sold 9,683 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $339K.
Parkwood LLC first reported a position in Inhibrx, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Parkwood LLC's Inhibrx, Inc. Common Stock position peaked at $339K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Parkwood LLC's 13F filing for Q2 2024, filed 14 Aug 2024.